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Research
Diabetes incidence is increasing worldwide. 
Increasing obesity and sedentary life  style are 
major risk factors, but other environ  mental 
factors may also be important. Toxicants 
such as polychlorinated biphenyls (PCBs) 
and dioxins are postulated to play a role, 
based on data from the National Health and 
Nutrition Examination Survey (NHANES) 
(Lee et al. 2006, 2007) and studies from the 
Slovak Republic (Langer et al. 2002; Radikova 
et al. 2004), Sweden (Lee et al. 2011a), Japan 
(Tanaka et al. 2011; Uemura et al. 2008), 
Taiwan (Wang et al. 2008), and the United 
States (Codru et al. 2007; Lee et al. 2010, 
2011b; Persky et al. 2011; Turyk et al. 2009a, 
2009b; Vasiliu et al. 2006), but the results are 
inconsistent. In addition, commentaries (Jones 
et al. 2008; Porta 2006) have emphasized the 
need for additional research.
PCBs were produced in Anniston, 
Alabama, from 1929 to 1971 in a plant 
that was purchased by the Monsanto 
Corporation in 1935. Large amounts of 
PCB-containing waste discharged during pro-
duction were revealed during litigation in 
Anniston (Grunwald 2002), with widespread 
contamination of soil, sediment, and air still 
found in the late 1990s [Agency for Toxic 
Substances and Disease Registry (ATSDR) 
2000]. Evaluation of PCB levels in sera from 
adults in Anniston collected from 1996 to 
1999 in smaller non  systematic studies, or as 
a part of litigation, indicated that this was 
one of the most highly exposed communities 
in the world (ATSDR 2000; Hansen et al. 
2003). In 2003, the ATSDR awarded fund-
ing to the Anniston Environmental Health 
Research Consortium (AEHRC) to conduct 
a health survey in Anniston adults. In this 
study, we examined the prevalence of diabetes 
in this population and the association of their 
serum PCB levels with diabetes.
Methods
Study population. The Anniston Community 
Health Survey employed a two-stage sampling 
procedure in which 3,320 households were 
randomly selected from a commercial list 
of all residential sites within the city limits. 
Addresses in west Anniston, the location of the 
former PCB manufacturing facility, were over-
sampled. All sampled addresses were visited 
by study staff: 489 were found to be vacant 
or non  residential, and residents of 890 could 
not be contacted after multiple attempts. 
Contact was made with a member of each 
of the remaining 1,823 targeted households, 
and 713 declined to participate. Among the 
remaining 1,110 consenting households, an 
adult > 18 years of age was randomly selected 
for survey completion, resulting in an overall 
participation rate of 61% (1,110/1,823). 
The study was reviewed and approved by 
the University of Alabama–Birmingham’s 
Institutional Review Board, and all participants 
provided written informed consent.
Data collection. The Anniston Community 
Health Survey included a 45-page question-
naire developed by the AEHRC. Demographic 
information, medical and family history, and 
health behaviors were recorded. The survey 
was administered by trained interviewers at 
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Ba c k g r o u n d: Polychlorinated biphenyls (PCBs) manufactured in Anniston, Alabama, from 1929 
to 1971 caused significant environmental contamination. The Anniston population remains one of 
the most highly exposed in the world.
oBjectives: Reports of increased diabetes in PCB-exposed populations led us to examine possible 
associations in Anniston residents.
Me t h o d s : Volunteers (n = 774) from a cross-sectional study of randomly selected households and 
adults who completed the Anniston Community Health Survey also underwent measurements 
of height, weight, fasting glucose, lipid, and PCB congener levels and verification of medications. 
Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to assess the relationships 
between PCBs and diabetes, adjusting for diabetes risk factors. Participants with pre  diabetes were 
excluded from the logistic regression analyses.
re s u l t s: Participants were 47% African American, 70% female, with a mean age of 54.8 years. The 
prevalence of diabetes was 27% in the study population, corresponding to an estimated prevalence 
of 16% for Anniston overall; the PCB body burden of 35 major congeners ranged from 0.11 to 
170.42 ppb, wet weight. The adjusted OR comparing the prevalence of diabetes in the fifth versus 
first quintile of serum PCB was 2.78 (95% CI: 1.00, 7.73), with similar associations estimated for 
second through fourth quintiles. In participants < 55 years of age, the adjusted OR for diabetes for 
the highest versus lowest quintile was 4.78 (95% CI: 1.11, 20.6), whereas in those ≥ 55 years of age, 
we observed no significant associations with PCBs. Elevated diabetes prevalence was observed with a 
1 SD increase in log PCB levels in women (OR = 1.52; 95% CI: 1.01, 2.28); a decreased prevalence 
was observed in men (OR = 0.68; 95% CI: 0.33, 1.41).
co n c l u s i o n s: We observed significant associations between elevated PCB levels and diabetes 
mostly due to associations in women and in individuals < 55 years of age.
key wo r d s: diabetes, epidemiology, polychlorinated biphenyls (PCBs), POPs. Environ Health 
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the homes of participants (October 2005–
April 2007). The length of the interview was 
typically 45–60 min.
Of the 1,110 individuals who completed 
the survey, 774 agreed to a clinic visit, which 
included measurements—by standard proto-
col—of height, weight, waist circum  ference, 
and blood pressure, as well as a review of 
current medications. Fasting blood was 
obtained for analyses of glucose and lipids 
(Jacksonville Medical Center, Jacksonville, 
AL), the major 35 ortho-substituted PCB 
congeners, and 13 pesticides and herbicides 
[Division of Laboratory Sciences at the 
Centers for Disease Control and Prevention’s 
(CDC) National Center for Environmental 
Health, Atlanta, GA]. The PCB congeners and 
pesticides were measured in serum using high-
resolution gas chromatography/isotope-dilution 
high-resolution mass spectrometry (Sjödin 
et al. 2004). Serum total lipids were calculated 
with the enzymatic summation method using 
triglyceride and total cholesterol measurements 
(Bernert et al. 2007).
Total wet-weight levels of the 35 PCB 
congeners in nanograms per gram (parts 
per billion) were summed (ΣPCBs). Before 
summation, values below the limit of detection 
(LOD) were substituted with the congener-
specific LOD divided by the square root of 
2. The ΣPCB variable was divided into 
quintiles, with the first quintile serving as the 
referent category. Quintile limits were based 
on values from the entire group with PCB 
measurements. Because the PCB distribution 
showed a positive skew, a log-transformed 
version of the continuous wet-weight total 
PCB variable was derived for trend assessment 
and for use in subgroup analyses. Consistent 
with recom  menda  tions from Schisterman et al. 
(2005), we evaluated both wet-weight PCB 
totals (nanograms per gram), with control for 
total lipids, and lipid-adjusted PCB values, 
but we report only the former here. Subsets 
of PCBs based on structure and function 
were summed (log-transformed) as follows: 
estrogenic congeners 44, 49, 66, 74, 99, 110, 
and 128 (DeCastro et al. 2006); mono-ortho 
congeners 28, 66, 74, 105, 118, 156, 157, 167, 
and 189; mono-ortho dioxin toxic equivalents 
(TEQ) 105, 118, 156, 157, 167, and 189 
(Van den Berg et al. 2006); di-, tri-, and tetra-
ortho congeners (combined) 44, 49, 52, 87, 
99, 101, 110, 128, 138+158, 146, 153, 170, 
172, 180, 194, 149, 151, 177, 178, 183, 187, 
195, 196+203, 199, 206, and 209; and the 
ryanodine-like congeners 52, 101, 149, 151, 
170, 180, 183, and 187 (activate ryanodine 
receptors at < 1 μM) (Pessah et al. 2006). In 
addition, we evaluated the possible association 
between log-transformed dichloro  diphenyl-
dichloro  ethylene (DDE) and diabetes.
For this study, diabetes was defined as 
self-report of physician-diagnosed diabetes or 
fasting glucose > 125 mg/dL. Prediabetes was 
defined as fasting glucose 100–125 mg/dL,   
absence of previously diagnosed diabetes, 
and absence of glycemic control medications. 
Normoglycemia was defined as individuals 
with a negative diabetes self-report, fasting 
glucose < 100 mg/dL, and the absence of 
glycemic control medications. Ever-smoking 
was defined as having smoked ≥ 100 ciga-
rettes over a lifetime. A positive family his-
tory of diabetes was defined as the presence 
of diabetes in siblings, parents, grandparents, 
aunts, or uncles. Participants were Caucasian 
(53%), African American (46%), and Native 
American (1%) and were grouped as white 
and non  white (African Americans, Native 
Americans) for purposes of these analyses.
Laboratory results [glucose, total choles-
terol, high-density lipoprotein (HDL), low-
density lipoprotein (LDL), triglycerides, PCB, 
and pesticide levels] were available for 765 of 
the 774 participants. Demographic informa-
tion was missing for < 3% of participants, 
with the exception of self-reported income 
(missing for 28%). Because individuals with 
missing data were excluded from the analy-
ses, income was not included as a measure of 
socio  economic status in multi  variable models.
Statistical analyses. Preliminary analyses 
included the calculation of frequencies, 
means, and SDs and the use of t-tests, one-
way analysis of variance, general linear models 
(GLMs), and Pearson’s chi-square test. A 
GLM was used to calculate geometric means 
(GMs) using the antilog of the log-transformed 
PCB mean value adjusted for age, sex, race/
ethnicity, or body mass index (BMI) (Bland 
and Altman 1996). Unconditional logistic 
Table 1. Participant characteristics and diabetes status: Anniston Community Health Survey.
Diabetes status
Characteristic
Normoglycemia 
(n = 396)
Prediabetes 
(n = 171)
Diabetes 
(n = 207)
Total 
(n = 774)
Age (years)* 51.4 ± 16.8 57.6 ± 13.9 58.7 ± 14.0 54.8 ± 15.9
No. of years in Anniston* 27.3 ± 19.3 29.1 ± 18.5 31.5 ± 19.9 28.8 ± 19.3
Total lipids (mg/dL)* 613.6 ± 138.3 671.6 ± 182.3 639.1 ± 158.3 633.3 ± 155.9
Sex*
Female 287 (72) 100 (59) 154 (74) 541 (70)
Male 109 (28) 71 (41) 53 (26) 233 (30)
Race/ethnicitya* 
White 226 (57) 88 (52) 97 (47) 411 (53)
Nonwhite 170 (43) 83 (48) 110 (53) 363 (47)
Age (years)*
18–34 69 (18) 10 (6) 11 (5) 90 (12)
35–44 67 (17) 20 (12) 20 (10) 107 (14)
45–54 84 (21) 39 (23) 47 (23) 170 (22)
55–64 82 (20) 42 (25) 50 (24) 174 (22)
65–74 56 (14) 43 (25) 53 (26) 152 (20)
≥ 75 38 (10) 17 (9) 26 (12) 81 (10)
BMI (kg/m2)*
< 18.5 5 (1) 0 (0) 0 (0) 5 (< 1)
18.5–24.9 122 (31) 18 (10) 25 (12) 165 (21)
25.0–29.9 106 (27) 56 (33) 43 (21) 205 (27)
30.0–34.9 87 (22) 52 (31) 52 (25) 191 (25)
35.0–39.9 39 (10) 26 (15) 43 (21) 108 (14)
≥ 40 36 (9) 18 (11) 44 (21) 98 (13)
Education
Through grade 8 37 (9) 14 (8) 25 (12) 76 (10)
Some high school 76 (20) 36 (21) 50 (24) 162 (21)
High school graduate 157 (40) 73 (43) 79 (38) 309 (40)
Some college 85 (22) 33 (19) 45 (22) 163 (21)
College graduate 36 (9) 14 (8) 8 (4) 58 (8)
Smoker
Never 185 (47) 70 (41) 96 (47) 351 (45)
Ever 211 (53) 100 (59) 110 (53) 421 (55)
Family history of diabetes*
No 165 (43) 62 (38) 53 (26) 280 (37)
Yes 219 (57) 103 (62) 151 (74) 473 (63)
Taking lipid-lowering medications*
No 339 (86) 128 (75) 120 (58) 587 (76)
Yes 57 (14) 43 (25) 87 (42) 187 (24)
Self-reported heart diseaseb* 
No 316 (80) 121 (71) 123 (60) 560 (73)
Yes 77 (20) 49 (29) 81 (40) 207 (27)
Data are n (%) or mean ± SD.
aOf the 363 non  whites, 359 were African American and 4 were Native American. bAny self-reported heart disease 
includes a history of myocardial infarction, congestive heart failure or other heart disease. *p ≤ 0.05 in one-way ANOVA 
(means) or Pearson chi-square test, across all diabetes status categories. PCBs and diabetes in Anniston
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regression modeling compared participants 
with and without diabetes by quintiles of 
the ΣPCBs. Participants were excluded from 
multi  variable analyses if they had pre  diabetes 
(n = 171) because many of their disease and 
demographic characteristics were intermediate 
to those observed in individuals with diabetes 
and those with normo  glycemia. Associations 
between PCB levels and established diabetes 
risk factors (BMI, family history of diabetes, 
age, race/ethnicity), sex, other possible 
confounders (i.e., education, marital status, 
smoking, duration of residence in Anniston), 
and diabetes were assessed through bivariate 
logistic regression analysis. Confounding 
was assessed in a second series of models that 
included PCBs and one of the established 
diabetes risk factors or potential confounders. 
Confounding was defined as a > 10% change 
in the β-coefficient and was evaluated by 
comparing point estimates for the PCB–
diabetes associations with and without the 
potential confounder. Final multi  variable 
models included PCB levels (quintiles or log 
transformed), age (continuous), sex (female/
male), race/ethnicity (white/non  white), family 
history of diabetes (no/yes), BMI (continuous 
or categorical: ≤ 24.9, 25.0–29.9, 30.0–34.9,   
35.0–39.9, ≥ 40 kg/m2), total lipids 
(continuous), and taking lipid-lowering drugs 
(no/yes).
Stratified analyses were performed by sex, 
race/ethnicity (white and non  white), BMI 
(≤ 24.9, 25.0–29.9, 30.0–39.9, ≥ 40 kg/m2), 
and age (< 55 and ≥ 55 years of age) because 
our initial data showed a striking number of 
younger adults with diabetes. The median 
age of the study population (55 years) was 
chosen as the cut point in the age-stratified 
analyses to have relatively equal sample sizes. 
The analytic strategy employed in the strati-
fied analyses was similar to that for the entire 
group of participants. Effect modification was 
assessed in full models using a backward step-
wise procedure and the likelihood ratio test; 
a p-value of ≤ 0.05 indicated the presence of 
effect modification.
Initial analyses were conducted using 
quintiles of the ΣPCB variable followed by 
analyses using the log-transformed wet-weight 
PCB variable to assess trend; odds ratios 
(ORs) associated with the log-transformed 
variables (ΣPCBs, PCB subsets, and DDE) 
were reported as a 1 SD increase. A gener-
alized additive model (GAM) (Hastie and 
Tibshirani 1990) was fitted using a cubic 
regression spline for the ΣPCBs to further 
examine the shape of the dose–response 
curve. Analyses evaluating subsets of PCBs 
(e.g., mono-ortho) and DDE were fitted using 
log-transformed versions of these variables. 
Covariables included in the GAM and the 
adjusted PCB subset models were identical 
to those used in the ΣPCB model. All final 
models report ORs and 95% confidence 
intervals (CIs). Analyses were conducted using 
SPSS (version 19; IBM, Chicago, IL) and 
R software (version 2.10.1; R Development 
Core Team 2010).
Log binomial models were fitted to assess 
the overall association between PCBs and 
diabetes because the prevalence of diabetes 
is 27%; ORs are more difficult to interpret 
than relative risks when the prevalence of the 
outcome is > 10–20% because they over-
estimate the effects. These binomial models 
failed to converge; consequently, in this article 
we present logistic regression results. 
Results
Participant characteristics are shown in 
Table 1. Non  whites (47%) were African 
American except for four Native Americans. 
The mean age of participants was 55 years 
(range, 18–93 years). Approximately 30% of 
the group had less than a high school educa-
tion, and 40% were high school graduates 
with no college. The mean duration of resi-
dence in Anniston among participants was 
28.8 years, with a range of 0.5–79 years. At 
the time of data collection, 85% of partici-
pants had lived in Anniston for ≥ 5 years, and 
11% were lifetime residents.
Diabetes was present in 27% of 774 
participants (self-report, n = 177; negative self-
report and fasting glucose values > 125 mg/dL,   
n = 30). Seventy-five percent of individuals 
self-reporting diabetes were taking glycemic 
control medications (data not shown). On 
average, participants classified as having 
diabetes or pre  diabetes were older than those 
classified as normo  glycemic (Table 1). The 
prevalences of pre  diabetes and diabetes were 
greatest in those between 45 and 74 years 
of age. The ratio of white to non  white 
participants was 1.3 in those without diabetes 
and 0.89 in those with diabetes (p = 0.05), 
suggesting a greater prevalence of diabetes 
in the non  white population. A greater 
proportion of participants with diabetes had 
BMIs ≥ 35 kg/m2, positive family histories of 
diabetes, and heart disease.
Relationships between PCB levels and 
diabetes status are shown in Tables 2 and 3. 
Participants with diabetes had significantly 
higher age-adjusted GM PCB levels than did 
those with pre  diabetes or normo  glycemia 
(Table 2); age-adjusted arithmetic means 
did not differ significantly by diabetes status. 
Age-adjusted GM PCB levels also were sig-
nificantly higher for both females and males 
classed as having diabetes compared with 
Table 2. PCB quintiles by diabetes status and age-adjusted PCB levels by diabetes status, sex, and race: 
Anniston Community Health Survey.
Diabetes status
Characteristic
Normoglycemia 
(n = 392)
Prediabetes 
(n = 169)
Diabetes 
(n = 205) Total (n = 766)
PCB quintile (ppb)a
Q1 (0.11–1.15) 105 (27) 32 (19) 16 (8) 153 (20)
Q2 (1.16–2.42) 82 (21) 27 (16) 44 (22) 153 (20)
Q3 (2.43–4.33) 65 (17) 39 (23) 50 (24) 154 (20)
Q4 (4.34–9.33) 84 (21) 36 (21) 33 (16) 153 (20)
Q5 (9.34–170) 56 (14) 35 (21) 62 (30)  153 (20)
ΣPCBs (ppb)a,b* 6.31 ± 0.58 (2.85) 6.14 ± 0.87 (3.13) 7.71 ± 0.80 (3.62) 6.72 ± 0.44 (3.18)
Sex
Females** 6.42 ± 0.63 (2.83) 6.31 ± 0.95 (3.09) 7.81 ± 0.83 (3.59) 6.85 ± 0.52 (3.16)
Males 5.99 ± 0.88 (2.91) 5.89 ± 1.02 (3.18) 7.39 ± 1.05 (3.69) 6.42 ± 0.76 (3.24)
Race/ethnicity
White# 3.45 ± 0.64 (1.88) 2.80 ± 0.92 (1.92) 3.99 ± 0.87 (2.11) 3.41 ± 0.57 (1.97)
Nonwhite 10.30 ± 0.72 (5.09) 9.65 ± 0.93 (5.21) 10.84 ± 0.84 (5.71) 10.26 ± 0.58 (5.33)
Data are n (%) or mean ± SE (GM). 
aPCB quintiles were derived from the ΣPCBs. bPCB levels were adjusted for age; separate age-adjusted models are 
presented for diabetes status alone, for diabetes status with sex, and for diabetes status with race/ethnicity. *p = 0.014 
for GMs compared across diabetes status. **p = 0.014 for GMs compared across diabetes status with sex in the model; 
no difference by sex. (p = 0.71). #p < 0.001 for GMs compared by race/ethnicity; no difference across diabetes status. 
(p = 0.25). 
Table 3. PCB levels (log ΣPCBs) by diabetes status, age, and BMI: Anniston Community Health Survey.
Diabetes status
BMI  
(kg/m2)
Normoglycemia (n = 392) Prediabetes (n = 169) Diabetes (n = 205) Total (n = 766)
< 55 years ≥ 55 years < 55 years ≥ 55 years < 55 years ≥ 55 years < 55 years ≥ 55 years
≤ 24.9 70 (1.13) 57 (6.31) 7 (3.87) 11 (5.23) 7 (4.45) 17 (4.16) 84 (1.40) 85 (5.67)
25–29.9 44 (1.58) 61 (4.90) 17 (3.17) 38 (5.48) 14 (2.41) 29 (7.25) 75 (2.00) 128 (5.54)
30–34.9 51 (1.19) 34 (4.18) 19 (1.45) 33 (5.24) 16 (2.76) 35 (5.44) 86 (1.45) 102 (4.92)
35–39.9 25 (1.27) 14 (5.98) 13 (1.99) 13 (4.29) 17 (2.06) 26 (9.43) 55 (1.64) 53 (6.90)
≥ 40 26 (1.23) 9 (6.01) 11 (1.30) 6 (6.87) 23 (1.87) 21 (7.26) 60 (1.46) 36 (6.86)
Data are [n (GM)]. This GLM model assessed age (< 55, ≥ 55), diabetes status (normo  glycemia, pre  diabetes, diabetes), 
BMI (five categories above), and log PCB levels. Parameter p-values from the GLM: age, p < 0.001; diabetes status, 
p < 0.001; BMI, p = 0.33. Silverstone et al.
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those with pre  diabetes or normo  glycemia. 
Although mean PCB levels for whites and 
non  whites were higher in those with diabetes 
than in those without diabetes, the differences 
were not statistically significant. GM PCB lev-
els were similar for males and females, whereas 
non  whites had significantly higher PCB levels 
than did whites. In general, PCB levels were 
higher in participants ≥ 55 years of age than 
in those < 55 years of age (Table 3). Within 
specific age strata, PCB levels remained simi-
lar across BMI categories for those ≥ 55 years 
of age. PCB levels showed inverse associations 
with BMI in younger individuals with diabe-
tes, and in those with pre  diabetes, although 
the trends were not statistically significant.
In a separate linear regression model, age, 
total lipids, total years living in Anniston, 
and non  white race showed significant positive 
associations with ΣPCBs, whereas we observed 
a significant inverse association for education. 
No association was observed for BMI in this 
model (data not shown).
Results from unadjusted logistic regression 
modeling indicated a significant increase in 
the prevalence of diabetes across each quintile 
of PCB exposure relative to the referent 
(first quintile); unadjusted ORs (95% CIs) 
for the second through fifth quintiles were 
3.51 (1.84, 6.67), 4.83 (2.53, 9.25), 2.66 
(1.37,  5.18), and 7.19 (3.79,  13.63), 
respectively. After adjustment for standard 
diabetes-related risk factors (family history, 
age, BMI, race/ethnicity), sex, total lipids, 
and lipid-lowering medications, the PCB 
point estimates for the second through fifth 
quintiles remained elevated but were similar 
in magnitude (Table 4). An attenuation in the 
log-transformed ΣPCB OR also was observed 
after adjustment for standard factors: The 
unadjusted OR was 1.65 (95% CI: 1.38, 1.99) 
per 1 SD increase in log PCBs, whereas the 
adjusted OR for the PCB–diabetes association 
was 1.23 (95% CI: 0.88, 1.72).
The GAM results in Figure 1 are similar 
to the quintile results, suggesting increasing 
diabetes risk with increasing serum PCBs, but 
possibly via a non  monotonic relation  ship, 
with a decrease between about 3 ppb and 
7 ppb. The sharp downtown in dose response 
at the high end of exposure is based on seven 
participants with PCB levels > 50 ppb, which 
precludes precise estimation.
Models stratified by age (< 55 and 
≥ 55 years) are shown in Table 4. In the 
younger participants, after adjustment for 
established diabetes-related risk factors, the 
likelihood of diabetes remained significant 
among those in the highest quintile relative to 
the lowest (OR = 4.78; 95% CI: 1.11, 20.60). 
Point estimates in the second and third quin-
tiles also were elevated among the younger 
participants but to a lesser extent. In the older 
participants, the ORs were elevated in each 
of the second through fifth quintiles, but 
the estimates were imprecise, with wide CIs, 
because the referent category (first quintile) 
comprised only five individuals.
Seventy percent of the study partici-
pants were female; analyses stratified by sex 
revealed a positive association between PCBs 
and diabetes in females and an inverse asso-
ciation in males. This was apparent in both 
the quintile and the log-transformed ΣPCB 
models (p < 0.05 for sex × PCB interaction 
terms). In the quintile model, three of four 
ORs were signifi  cantly elevated in females, 
whereas three of four ORs were < 1.0 in men; 
each CI included the null value in the analysis 
of males. The adjusted OR associated with a 
1 SD increase in log-transformed PCBs was 
1.52 (95% CI: 1.01, 2.28) in females and 0.68 
(95% CI: 0.33, 1.41) in males (Table 5).
Results from the analyses of log-trans-
formed PCB subsets (e.g., mono-ortho, estro-
genic), DDE, and diabetes (Table 5) were 
comparable to results for ΣPCBs in the total 
group and in the sex-stratified analyses. In 
females, adjusted ORs were significantly 
elevated for each congener subset, with the 
exception of the estrogenic PCBs. ORs were 
< 1.0 for males and were non  significant for 
all congener subsets; there were 153 males 
in this analysis compared with 427 females. 
DDE was associated with a significantly 
increased log OR of diabetes in women 
(OR = 1.42; 95% CI: 1.03, 1.95) but not 
in men (OR = 0.61; 95% CI: 0.32, 1.15), a 
finding also reported by Turyk et al. (2009a, 
2009b).
Discussion
We found a high prevalence of diabetes in 
our study population—residents of an area 
surrounding the oldest former PCB pro-
duction facility in the United States. Using 
logistic and GAM modeling, we observed a 
non  monotonic increase in the prevalence of 
diabetes with increasing PCB congener levels 
in the total group after adjustment for estab-
lished diabetes risk factors. We also observed 
a significantly elevated OR in the highest 
quintile among individuals < 55 years of age. 
Among individuals ≥ 55 years of age, adjusted 
ORs were elevated in all quintiles relative 
to the first quintile; however, the CIs were 
imprecise because only five participants in 
this age group had PCB values in the lowest 
quintile. In the total study group, the adjusted 
ORs for the PCB subsets and DDE were 
simi  lar to the ΣPCB estimate. Women had 
an increased likelihood of diabetes not only 
for ΣPCB but also for DDE and each subset 
of PCBs examined, with the exception of the 
estrogenic subset; men had a decreased likeli-
hood of diabetes based on a much smaller 
number of observations.
PCB levels in our participants exceeded 
those observed in the general U.S. population 
and in previously reported community 
exposures. Lee et al. (2007) found an 
increased prevalence of diabetes in NHANES 
participants 40–59 years of age in the top 
quarter of the distribution of a mixture of 
six persistent organic pollutants, including 
pesticides and dioxins. Although adjusted for 
most risk factors, their model was not adjusted 
for family history of diabetes; moreover, 
individuals with pre  diabetes were not 
excluded. For comparison, the top value in the 
lowest quartile in the present study (1.43 ppb) 
is within the NHANES third quartile (50th 
to 75th percentile), whereas the third and 
fourth quartiles are several times higher 
(quartile 3 = 3.29–7.42 ppb; quartile 4 =   
7.43–171 ppb) (Pavuk et al. 2009). In other 
studies that evaluated the association of 
diabetes (Codru et al. 2007; Lee et al. 2006, 
2010, 2011a; Turyk et al. 2009a, 2009b; 
Vasiliu et al. 2006), PCB serum concentrations 
were mostly less than those found 35 years 
Table 4. Logistic regression models of PCB quintiles and diabetes for the total group and with stratification by age: Anniston Community Health Survey.
Total group (n = 580) < 55 years (n = 288) ≥ 55 years (n = 292)
Characteristic n (diabetes/control) OR (95% CI) n (diabetes/control) OR (95% CI) n (diabetes/control) OR (95% CI)
PCB quintile (ppb)
Q1 (0.11–1.15) 16/102 1.00 (reference) 15/99 1.00 (reference) 1/4 1.00 (reference)
Q2 (1.16–2.42) 44/80 2.18 (0.98, 4.82) 25/46 2.44 (0.91, 6.53) 19/34 4.47 (0.28, 71.38)
Q3 (2.43–4.33) 47/62 2.91 (1.24, 6.83) 17/30 2.29 (0.71, 7.39) 30/32 8.45 (0.53, 134.99)
Q4 (4.34–9.33) 33/79 1.64 (0.64, 4.19) 7/25 1.14 (0.36, 5.52) 26/54 3.74 (0.23, 59.62)
Q5 (9.34–170) 62/55 2.78 (1.00, 7.73) 12/12 4.78 (1.11, 20.6) 50/43 4.19 (0.26, 68.12)
Log PCB per 1 SD increasea 202/378 1.23 (0.88, 1.72) 76/212 1.52 (0.89, 2.58) 126/166 0.93 (0.58, 1.58)
PCB quintiles and the log-transformed PCB variable were derived from the ΣPCBs, wet weight. Individuals with prediabetes were excluded from all models. Covariables were age, sex, 
BMI (continuous), total lipids, race/ethnicity, family history of diabetes, and taking lipid-lowering medication. Controls are individuals with normoglycemia. 
aThe same covariables were used in both log-transformed PCB models and quintile models. PCBs and diabetes in Anniston
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after production stopped in Anniston. The 
frequency of diabetes reported in other studies 
is 5–20%. The estimated weighted prevalence 
of diabetes in the Anniston population 
(adjusted for age, race/ethnicity, sex, and over-
sampling in west Anniston) was 16%, which 
corresponded to an unweighted prevalence 
in the study cohort of 27% in 2005–2007. 
The weighted prevalence for Anniston is 
comparable to the higher reported values from 
other PCB and diabetes studies and above the 
prevalence of self-reported diagnosed diabetes 
in Alabama in 2005 (9.8%) and in 2008 
(11.2%) (CDC 2005, 2008).
In the total group logistic and GAM mod-
els, and in participants < 55 years of age, our 
analyses suggest an increase in the odds of 
diabetes with increasing PCB levels, although 
the increase does not appear to be monotonic. 
Our findings are suggestive of a relatively low-
dose PCB effect in the Anniston study popu-
lation because the ORs increase in the second 
quintile and remain elevated in all quintiles. 
Low-dose effects of PCBs were reported in the 
Coronary Artery Risk Development in Young 
Adults (CARDIA) study (Lee et al. 2010). 
In the present study, we observed an asso-
ciation between PCBs and diabetes in younger 
participants, but not in those ≥ 55 years of 
age. Our observations in younger Anniston 
residents are consistent with findings from the 
CARDIA study in which the PCB–diabetes 
associations were noted in individuals between 
36 and 52 years of age (Lee et al. 2010). The 
lack of association in older Anniston par-
ticipants contrasts with findings from the 
Prospective Investigation of the Vasculature 
in Uppsala Seniors (PIVUS) study (Lee et al. 
2011a), a longitudinal study of elderly in 
Uppsala, Sweden. The Anniston study group 
was approximately 50% African American. 
Other demographic factors and/or differences 
in access to medical care between Anniston 
and Uppsala residents likely complicate 
comparison of the findings across these two 
populations.
Additional strengths of our study include 
fasting glucose measurements and the ability to 
distinguish individuals with pre  diabetes from 
the normoglycemic. These participants had 
charac  teristics intermediate to those with and 
without diabetes. For example, 29% of partici-
pants classed as having pre  diabetes self-reported 
heart disease, compared with 20% of those 
with normo  glycemia and 40% with diabetes. 
Because of differences in these charac  teristics, 
exclusion of participants with pre  diabetes in 
the referent group was the physiologically and 
mechanistically preferable choice.
Our observation that PCBs were positively 
associated with diabetes in women is similar 
to that reported for cohorts exposed to PCBs 
and furans in contaminated rice oil in Taiwan 
(Wang et al. 2008) and for women exposed to 
polybrominated biphenyls (PBBs) and PCBs 
through contaminated milk and animal feed 
in Michigan (Vasiliu et al. 2006). Results of 
these studies, however, were not adjusted for 
family history or pre  diabetes. Excess diabetes 
risk in exposed females may be secondary to 
a higher percentage of body fat, allowing for 
greater accumulation and retention of lipo-
philic compounds. Other possible mecha-
nisms include estrogenic activities found in 
PCB congeners and their metabolites possibly 
affecting glucose metabolism.
There are several mechanisms that could 
provide biological plausibility to the observed 
associations between diabetes and PCBs, 
dioxins, and other organochlorines, including 
altered gene transcription, lipid metabolism, 
insulin production, changes in the insulin sig-
naling pathway (Marchand et al. 2005), and 
altered glucose transport (Tonack et al. 2007). 
The association of diabetes and PCBs is also 
complicated by changes in lipid metabo  lism 
caused by diabetes, which may affect the dis-
tribution and elimination of lipophilic PCBs, 
as perhaps suggested by lower PCBs in higher 
BMI categories in those with diabetes and 
pre  diabetes. Because repeated measure  ments 
of PCBs or lipids were not performed, these 
changes (or possible reverse causality) could 
not be evaluated. Although the slower elimi-
nation of dioxin in participants with diabetes 
was not supported by findings in the Vietnam 
Veterans study (Michalek et al. 2003), the 
cross-sectional nature of our study precludes 
making inferences.
PCBs were produced in Anniston from 
1929 to 1971, and this study was under-
taken in 2005–2006, at the same time that 
major remediation began in Anniston. The 
average duration of residency in Anniston 
among partici  pants was 28.8 years. Congeners 
measured in our study participants included 
those with transient half-lives (e.g., PCB con-
geners 18, 44, 101, 110, and 151) and those 
with half-lives of > 15 years (e.g., PCB con-
geners 118, 138, 170) (Emond et al. 2005; 
Hansen 2001; Ogura 2004). PCB levels 
among 1,384 partici  pants measured in 1976 
in the Michigan PBB cohort were (from low 
to high, in quartiles) ≤ 5, 5.1–7.0, 7.1–10.0, 
and > 10 ppb (Vasiliu et al. 2006). These PCB 
quartile ranges are similar to those observed 
in Anniston in 2005, 35 years after PCB pro-
duction ended; the Anniston quartile ranges, 
from low to high, were ≤ 1.43, 1.44–3.28, 
3.29–7.42, and 7.43–171 ppb. It is likely that 
the PCB levels in most Anniston residents have 
decreased since the end of PCB production. 
In the Michigan PBB cohort, total PCB lev-
els remained stable in 37.5% of participants, 
increased in 12.2%, and decreased in 50.3% 
over time in samples collected between 1975 
and 1994 (Sweeney et al. 2001).
Households were randomly selected for 
participation in the present study, as were 
individuals within households. Although 
selection bias cannot be ruled out, there 
were no significant differences by race or sex 
Figure  1.  GAM  results  for  serum  ΣPCB 
concentration (ppb wet weight) and OR for diabetes, 
adjusted for age, sex, BMI (continuous), total lipids, 
race, family history of diabetes, and taking lipid-
lowering medications. The OR referent is the lowest 
PCB measurement, and dashed lines represent the 
95% point  wise confidence band. The tick marks on 
the x-axis represent PCB measurements for each 
person.
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Table 5. Logistic regression [OR (95% CI)] of ΣPCBs, PCB subsets, DDE, and diabetes in the total group 
and with stratification by sex: Anniston Community Health Survey.
Exposure variable Total group (n = 580) Females (n = 427) Males (n = 153)
PCB quintile (ppb)
Q1 (0.11–1.15) 1.00 (reference) 1.00 (reference) 1.00 (reference)
Q2 (1.16–2.42) 2.18 (0.98, 4.82) 3.14 (1.25, 7.89) 0.45 (0.08, 2.63)
Q3 (2.43–4.33) 2.91 (1.24, 6.83) 3.26 (1.21, 8.78) 1.08 (0.15, 7.71)
Q4 (4.34–9.33) 1.64 (0.64, 4.19) 2.47 (0.84, 7.30) 0.30 (0.03, 2.76)
Q5 (9.34–170) 2.78 (1.00, 7.73) 4.87 (1.47, 16.12) 0.29 (0.03, 3.09)
ΣPCBs per 1 SD increase 1.21 (0.87, 1.69) 1.52 (1.01, 2.28) 0.68 (0.33, 1.41)
PCB subsets per 1 SD increase
Mono-ortho 1.18 (0.86, 1.62) 1.47 (0.99, 2.17) 0.74 (0.38, 1.42)
Estrogenic 1.08 (0.80, 1.46) 1.28 (0.89, 1.84) 0.74 (0.40, 1.38)
Di-, tri-, or tetra-ortho 1.20 (0.86, 1.68) 1.50 (1.00, 2.23) 0.68 (0.33, 1.43)
Ryanodine 1.19 (0.85, 1.66) 1.49 (1.00, 2.23) 0.66 (0.32, 1.337
Mono-ortho TEQ 1.20 (0.87, 2.02) 1.51 (1.02, 2.24) 0.71 (0.36, 1.39)
DDE per 1 SD increase 1.22 (0.85, 1.46) 1.42 (1.03, 1.95) 0.61 (0.32, 1.15)
PCB quintiles and the log-transformed PCB variable were derived from the ΣPCBs, wet weight. All congener subsets and 
DDE were log transformed. Individuals with prediabetes were excluded from all models. Covariables in adjusted models 
were age, BMI (continuous-PCB quintile models, categorical-log transformed models), total lipids, race/ethnicity, family 
history of diabetes, and taking lipid-lowering medication. Sex was included in total group models. Silverstone et al.
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among those with and without labora  tory 
testing. Older individuals were more likely to 
have blood testing, as were individuals who 
were not employed or were retired (p < 0.05), 
an observation that is consistent with less 
flexible schedules and/or less concern about 
health among younger participants. Older 
participants also had higher rates of diabetes, 
but those were not found to be statistically 
associated with PCB levels.
Although the ORs (95% CIs) are inter-
nally valid as descriptors of associations in our 
study, they may not represent associations in 
Anniston as a whole because of our complex 
sampling design and exclusion of individuals 
with pre  diabetes.
Conclusions
This study demonstrates a statistically signifi-
cant association of serum PCB levels with 
increased diabetes prevalence overall, espe-
cially among women. Additionally, the most 
highly exposed individuals < 55 years of age 
had an elevated risk of diabetes.
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